Publications by authors named "Mirna Moloney"
Background: In 2014, UNAIDS set a goal to end the AIDS epidemic by achieving targets for the percentage of people living with HIV who were aware of their status, on antiretroviral therapy (ART), and virally suppressed. In 2020, these targets were revised to 95% for each measure (known as 95-95-95), to be reached among people living with HIV by 2025. We used data from the Fifth Botswana AIDS Impact Survey (BAIS V) to measure progress towards these testing and treatment targets in Botswana.
View Article and Find Full Text PDFArticle Synopsis
- * A study conducted in Nigeria's Enugu, Gombe, Lagos, and Nasarawa states found that seroprevalence of SARS-CoV-2 antibodies ranged from 9.3% to 25.2%, with over 96% of interviewed individuals providing blood samples
- * Despite a high seroprevalence indicating infection rates much higher than officially reported cases, active SARS-CoV-2 infection was low at 0.2%, suggesting that most of the population remained susceptible to COVID-19
Objective: Viral load suppression (VLS) is critical in reducing morbidity and mortality associated with HIV as well as minimizing the likelihood of HIV transmission to uninfected persons. The objective of this study was to identify factors associated with VLS among people living with HIV (PLWH) on antiretroviral (ARV) therapy to inform HIV programme strategies in Nigeria.
Methods: Adult participants, aged 15-64 years, from the 2018 Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS), who self-reported to be a PLWH or had detectable ARVs, were analysed to examine factors associated with VLS defined as HIV RNA <1000 copies/mL.